Suppr超能文献

尿石症的医学评估和管理。

Medical evaluation and management of urolithiasis.

机构信息

The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

出版信息

Ther Adv Urol. 2010 Feb;2(1):3-9. doi: 10.1177/1756287210369121.

Abstract

Nephrolithiasis is a highly prevalent condition with a high recurrence rate that has a large impact on the quality of life of those affected. It also poses a great financial burden on society. There have been great advancements in the surgical treatment of stone disease over the past several decades. The evolution of surgical technique appears to have overshadowed the importance of prevention of stone disease despite evidence showing medical therapies significantly decreasing stone recurrence rates. Herein we review the metabolic evaluation of stone formers with the use of specific blood and urine tests. We complete our discussion with a review of the medical management of stone formers providing both general recommendations as well as reviewing focused therapies for specific metabolic abnormalities and medical conditions.

摘要

肾结石是一种高发疾病,复发率高,对患者的生活质量有很大影响,同时也给社会带来了巨大的经济负担。在过去的几十年中,结石病的外科治疗取得了很大的进展。尽管有证据表明药物治疗可以显著降低结石复发率,但手术技术的发展似乎掩盖了结石病预防的重要性。本文回顾了结石患者的代谢评估,包括使用特定的血液和尿液检查。我们还讨论了结石患者的药物治疗,提供了一般建议,并回顾了针对特定代谢异常和医疗状况的针对性治疗。

相似文献

1
Medical evaluation and management of urolithiasis.
Ther Adv Urol. 2010 Feb;2(1):3-9. doi: 10.1177/1756287210369121.
2
Urolithiasis: Update on Metabolic Evaluation of Stone Formers.
ScientificWorldJournal. 2005 Nov 11;5:902-914. doi: 10.1100/tsw.2005.118. eCollection 2005.
3
Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers.
Asian J Urol. 2018 Oct;5(4):235-242. doi: 10.1016/j.ajur.2018.06.007. Epub 2018 Jun 26.
4
Update on nephrolithiasis management.
Minerva Urol Nefrol. 2007 Sep;59(3):317-25.
5
Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20.
6
No stone unturned: The epidemiology and outcomes of paediatric urolithiasis in Manchester, United Kingdom.
J Pediatr Urol. 2020 Jun;16(3):372.e1-372.e7. doi: 10.1016/j.jpurol.2020.03.009. Epub 2020 Mar 19.
8
Urolithiasis--medical therapies.
BJU Int. 2011 Nov;108 Suppl 2:9-13. doi: 10.1111/j.1464-410X.2011.10688.x.
9
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.

引用本文的文献

4
Predictive Factors for Achieving the Recommended AUA Daily Urine Production in Patients With Nephrolithiasis.
Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):141-148. doi: 10.1016/j.mayocpiqo.2019.02.006. eCollection 2019 Jun.
5
Protective effect of ethyl acetate fraction of extract against sodium oxalate-induced urolithiasis in rats.
J Tradit Complement Med. 2017 Jan 17;7(4):476-486. doi: 10.1016/j.jtcme.2016.12.012. eCollection 2017 Oct.
6
Detector-based spectral CT with a novel dual-layer technology: principles and applications.
Insights Imaging. 2017 Dec;8(6):589-598. doi: 10.1007/s13244-017-0571-4. Epub 2017 Oct 6.
7
Effects of commercial citrate-containing juices on urolithiasis in a Drosophila model.
Kaohsiung J Med Sci. 2013 Sep;29(9):488-93. doi: 10.1016/j.kjms.2013.01.003. Epub 2013 Apr 20.
8
Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones.
Urolithiasis. 2013 Aug;41(4):315-22. doi: 10.1007/s00240-013-0568-5. Epub 2013 May 10.

本文引用的文献

2
Effect of potassium depletion on urinary stone risk factors in Wistar rats.
Urol Res. 2009 Dec;37(6):311-6. doi: 10.1007/s00240-009-0220-6. Epub 2009 Oct 16.
5
Medical therapy of stone disease: from prevention to promotion of passage options.
Curr Urol Rep. 2009 Jan;10(1):29-34. doi: 10.1007/s11934-009-0007-x.
6
Urinary metabolic evaluations in solitary and recurrent stone forming children.
J Urol. 2008 Jun;179(6):2369-72. doi: 10.1016/j.juro.2008.01.151. Epub 2008 Apr 23.
7
Prevention of stone disease.
Urol Int. 2007;79 Suppl 1:37-46. doi: 10.1159/000104440.
8
Laboratory assessment.
Urol Int. 2007;79 Suppl 1:20-5. doi: 10.1159/000104437.
9
Renal histopathology of stone-forming patients with distal renal tubular acidosis.
Kidney Int. 2007 Apr;71(8):795-801. doi: 10.1038/sj.ki.5002113. Epub 2007 Jan 31.
10
Renal stone disease: Causes, evaluation and medical treatment.
Arq Bras Endocrinol Metabol. 2006 Aug;50(4):823-31. doi: 10.1590/s0004-27302006000400027.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验